- Visibility 118 Views
- Downloads 96 Downloads
- Permissions
- DOI 10.18231/j.ijmr.12417.1896146274
-
CrossMark
Hidden burden: Hepatitis C virus infection among multi-transfused thalassemic children in Gujarat
- Author Details:
-
Saurabh Chhotalal Norris
-
Pankti C Pargi *
-
Binda Prakashbhai Pipaliya
-
Rachana Dhirubhai Patel
-
Tanuja Bakul Javadekar
Saurabh Chhotalal Norris
Pankti C Pargi *
Binda Prakashbhai Pipaliya
Rachana Dhirubhai Patel
Background: Thalassemia is a genetic hemoglobinopathy leading to chronic anemia, frequently requiring regular blood transfusions. Recurrent transfusions elevate the risk of transfusion-transmitted infections (TTIs), including hepatitis B virus (HBV), hepatitis C virus (HCV), HIV, and syphilis. Iron overload also remains a serious complication. This study aimed to assess the prevalence of HCV infection in β-thalassemia major children receiving multiple transfusions.
Materials and Methods: A cross-sectional study was conducted at the Department of Microbiology, tertiary care centre, Vadodara, from February to July 2024. A total of 119 thalassemic children with regular transfusion history were included. Serum samples were first screened using the Qualisa third-generation ELISA for anti-HCV antibodies. All ELISA-reactive samples were further confirmed using qualitative real-time PCR to detect HCV RNA, ensuring diagnostic precision. Demographic and transfusion data were collected through caregiver interviews.
Results: Out of 119 participants, 16 (13.45%) were confirmed HCV RNA-positive using qualitative PCR. The highest prevalence was noted in the 9–12 years age group. A strong correlation was observed between the number of transfusions and HCV positivity, with a 60% positivity rate in those who received more than 100 transfusions. Additional factors such as rural residence, splenectomy, and lack of chelation therapy were associated with higher HCV rates.
Conclusion: This study emphasizes the high burden of HCV among multi-transfused thalassemic children and advocates for routine NAT/PCR screening and continuous HCV surveillance in high-risk pediatric groups.
References
- Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science. 1989;244(4902):359–62.
- Alter HJ, Holland PV, Purcell RH, Lander JJ, Feinstone SM, Morrow AG, et al. Posttransfusion hepatitis after exclusion of commercial and hepatitis-B antigen-positive donors. Ann Intern Med. 1972;77(5):691–9.
- Lok AS, McMahon BJ. Chronic hepatitis B: update 2009. Hepatology. 2009;50(3):661–2. 422 Norris et al. / Indian Journal of Microbiology Research 2025;12(3):419–422
- Lavanchy D. Evolving epidemiology of hepatitis C virus. Clin Microbiol Infect. 2011;17(2):107–15.
- Colah R, Gorakshakar A, Nadkarni A. Global burden, distribution and prevention of β-thalassemias and hemoglobin E disorders. Expert Rev Hematol. 2010;3(1):103–17.
- World Health Organization. Global hepatitis report 2017. Geneva: World Health Organization; 2017. (WHO/CDS/HIV/18.46). Available from: https://apps.who.int/iris/handle/10665/255016
- Dhiman RK, Grover GS, Premkumar M, Taneja S, Duseja A, Arora S, et al.; MMPHCRF Investigators. Decentralized care with generic direct-acting antivirals in the management of chronic hepatitis C in a public health care setting. J Hepatol. 2019;71(6):1076–85.
- Cappellini MD, Cohen A, Porter J, Taher A, Viprakasit V, editors. Guidelines for the management of transfusion dependent thalassaemia (TDT). 3rd ed. Nicosia (CY): Thalassaemia International Federation; 2014.
- Shrivastava M, Kumar S, Navaid S, Chotrani D, Dwivedi R. A cross- sectional study on burden of hepatitis C, hepatitis B, HIV and syphilis in multi-transfused thalassemia major patients reporting to a government hospital of Central India. Indian J Hematol Blood Transfus. 2015;31(3):367–73.
- Verma IC, Saxena R, Kohli S. Past, present & future scenario of thalassaemic care & control in India. Indian J Med Res. 2011;134(4):507–21.
- World Health Organization. Global health sector strategy on viral hepatitis, 2016–2021: towards ending viral hepatitis. Geneva: World Health Organization; 2016. Available from: https://apps.who.int/iris/handle/10665/246177.
- Gorakshakar AC, Ghosh K. Transfusion transmitted infections in Indian thalassemics: a perspective. Indian J Hematol Blood Transfus. 2013;29(3):189–90.
- Vidja PJ, Vachhani JH, Sheikh SS, Santwani PM. Blood transfusion transmitted infections in multiple blood transfused patients of beta thalassaemia. Indian J Hematol Blood Transfus. 2011;27(2):65–9.
- Mahmoud RA, El-Mazary AA, Khodeary A. Seroprevalence of hepatitis C, hepatitis B, cytomegalovirus, and human immunodeficiency viruses in multitransfused thalassemic children in Upper Egypt. Adv Hematol. 2016;2016:9032627.
- Modi D, Rathod GB, Delwadia KN, Goswami HM. Study of seroprevalence in thalassemic patients. Int Arch Integr Med. 2016;3(4):57-65.
- Agrawal S, Sulaniya PK, Garg K, Choudhary R, Sulaniya C. Seroprevalence of hepatitis-C infection in multi-transfused thalassemic children: study from a West Indian tertiary care center. Int J Contemp Pediatr. 2017;4(5):1871–4. Cite this article: Norris SC, Pargi PC, Pipaliya BP, Patel RD, Javadekar TB. Hidden burden: Hepatitis C virus infection among multi-transfused thalassemic children in Gujarat. Indian J Microbiol Res. 2025;12(3):419–422.